Splicing factor SRSF1 promotes gliomagenesis via oncogenic splice-switching of MYO1B

Abnormal alternative splicing (AS) caused by alterations to splicing factors contributes to tumor progression. Serine/arginine splicing factor 1 (SRSF1) has emerged as a key oncodriver in numerous solid tumors, leaving its roles and mechanisms largely obscure in glioma. Here, we demonstrate that SRS...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Clin Invest
Главные авторы: Zhou, Xuexia, Wang, Run, Li, Xuebing, Yu, Lin, Hua, Dan, Sun, Cuiyun, Shi, Cuijuan, Luo, Wenjun, Rao, Chun, Jiang, Zhendong, Feng, Ying, Wang, Qian, Yu, Shizhu
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Clinical Investigation 2019
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6355305/
https://ncbi.nlm.nih.gov/pubmed/30481162
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI120279
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы